Regulatory Timeline Expectations for Post-Approval Expiry Changes
Regulatory delays in shelf life updates can result in:
Click to read the full article.
Shelf Life and Expiry
Impact of Packaging Changes on Shelf Life Extension Approval
Not all packaging changes are created equal. Agencies classify them based on their potential impact on product quality and stability. Key packaging changes include:
Click to read the full article.
Designing an SOP for Shelf Life Re-Evaluation After Packaging Change
A formal SOP provides:
Click to read the full article.
How to Link Ongoing Studies to Shelf Life Extension Submissions
Linking real-time or ongoing studies serves several purposes:
Click to read the full article.
Training Regulatory Teams on Stability-Based Labeling Changes
Labeling updates based on shelf life extensions go beyond simple date modifications. They involve:
Click to read the full article.
Bracketing Studies for Cost-Effective Shelf Life Extensions
Bracketing is a type of reduced stability design defined in ICH Q1D. It involves selecting only the extremes (highest and lowest strengths or container sizes) for stability testing, under the assumption that intermediate configurations will behave similarly.
Click to read the full article.
Checklist for Global Filing of Shelf Life Extension Data
Ensure your submission updates the correct CTD modules for each region:
Click to read the full article.
Understanding the Difference Between Re-Test Period and Shelf Life
The re-test period is the duration during which an Active Pharmaceutical Ingredient (API) is expected to remain within its approved specification and may be used, provided it passes a re-test before further processing.
Click to read the full article.
How to Establish Re-Test Dates for APIs and Intermediates
The re-test period is the time span during which an API or intermediate is expected to remain within specification if stored under recommended conditions. After this period, the material must be tested again before use. If it meets the quality criteria, it can continue to be used.
Click to read the full article.
Checklist for Re-Test Period Documentation in Pharma QA Systems
Documenting re-test periods is not just a regulatory formality—it ensures that pharmaceutical materials remain suitable for use over time. A structured QA checklist enhances traceability, reduces risk of non-compliance, and prepares your team for regulatory inspections. By following this 10-point documentation framework, pharma companies can establish a gold-standard quality assurance system for re-test management.
Click to read the full article.